Rawat Siddharta

Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma.

Sonali M. Smith, R. Fisher, Y. Oki, 2019, Clinical lymphoma, myeloma & leukemia.